Immunohistochemistry (IHC), which utilizes monoclonal and polyclonal antibodies to detect specific antigens in situ, is a very powerful tool for imaging discrete components in tissues. The science of IHC is evolving, as evidenced by the development of increasingly sophisticated automated staining platforms, production of specific antibodies against a wide range of species, and the availability of a range of novel biomarkers.
No takes yet. Share an insight, caveat, or question.
Hannah Cole (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: